Binding Mode of Cyclic Chemerin‐9 Peptide and ChemerinS157 Protein at CMKLR1
The chemokine-like receptor 1 (CMKLR1) is activated by the adipokine and chemoattractant protein chemerin. Cryo-EM structures of chemerin-9-CMKLR1-Gi have been published, where chemerin-9 is the nonapeptide of the C terminus of chemerinS157. Chemerin-9 is as active as the full-length protein in Ca<sup>2+</sup>-release but shows differences in equilibrium read-outs. An equally potent cyclic chemerin-9 variant (cC9) was reported previously. Now, we have built a computational model of CMKLR1 to investigate the binding mode of cC9 and chemerinS157 in comparison to chemerin-9. Differences were investigated using CMKLR1 variants. Double-mutant cycle analysis identified CMKLR1-F2.53 as the relevant position for Phe8-binding of cC9. Energy contribution revealed slight differences in Phe8-binding to CMKLR1-F2.53 and space for larger residues. This was confirmed as the chemerin-9 variant with 1-naphthyl-L-alanine at position 8 showed a 4-fold increased potency of 2 nM (pEC<sub>50</sub>=8.6±0.15). While chemerin-9 and cC9 share their interactions at the CMKLR1, chemerinS157 tolerates most mutations of CMKLR1 in the deep binding site. The computational model of chemerinS157 suggests a β-sheet interaction between the N-terminal CMKLR1-segment I25VVL28 and the β-sheet D108KVLGRLVH116 of ChemS157, which was confirmed experimentally. Our data add to the knowledge by identifying the binding mode of chemerinS157 and cC9 at CMKLR1, facilitating the future structure-based drug design.
Authors
- Tina Schermeng (ORCID: https://orcid.org/0000-0001-7508-3574)
- Jens Meiler (ORCID: https://orcid.org/0000-0001-8945-193X)
- Fabian Ließmann (ORCID: https://orcid.org/0009-0007-9199-1629)
- Annette G. Beck‐Sickinger (ORCID: https://orcid.org/0000-0003-4560-8020)
- Carla Katharina Ambrosius (ORCID: https://orcid.org/0009-0006-5723-3616)
Institutions
- Vanderbilt University (US)
- Leipzig University (DE)
Publication Details
- Journal
- ChemBioChem
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1002/cbic.202400695
- Citations
- 2
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.48
Funders
- Deutsche Forschungsgemeinschaft